16
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Literature Alerts

Pages 519-534 | Published online: 29 Sep 2008

LITERATURE ALERTS

  • A microsphere-lipoplex (microplex) vector for targeted gene therapy of cancer. I. Construction and in vitro evaluation. HASS, C. R., WALKER, T. L., KALLE, W. H. J., and BURTON, M. A., Drug Delivery, 1999, 6,259–269.
  • A new high transmission infinite range mass selector for cluster and nanoparticle beams. VON ISSENDOR, B., and PALMER, R. E., Review of Scientific Instruments, 1999, 70, 4497–4501.
  • A new microparticle program for papermaking retention and drainage applications LA-German. GERLI, A., and BLEIER, H., Wochenblatt fur Papierfabrikation, 1999, 127, 1396–1398.
  • A new surface-enhanced Raman scattering substrate based on silver nanoparticles in sol-gel. VoLKAN, M., STOKES, D. L., and Vo DINH, T Journal of Raman Spectroscopy, 1999, 30, 1057–1065.
  • A new synthetic method toward bimetallic ruthenium platinum nanoparticles; composition induced structural changes. PAN, C., DASSENOY, F., CASANOVE, M. J., PHILIPPOT, K., AMIENS, C., LECANTE, P., MOSS1 1, A., and CHAUDRET, B. Journal of Physical Chemistry B, 1999, 103, 10 098-10 101.
  • A novel route for the preparation of CuSe and CuInSe2 nanoparticles. MALIK, Air A n' PtRIEN, P., and REVAPRASADU, N., Advanced Materials, 1999, 11, 1441–1444.
  • A novel route for the preparation of narrow particle size distribution emulsions and microcapsules. LUBETKIN, S., MULQUEEN, P., and PATERSON, E., Pesticide Science, 1999, 55, 1123–1125.
  • A preliminary report of L-NDDP (platar), liposomal cisplatin analog, in patients with refractory peritoneal carcinomatosis or sarcomatosis: a phase I study. VERSCHRAEGEN, C. F., ROYCE, M., MANSELD, P., FEIG, B., HUNT, K., SIDDIK, Z., NELSON TAYLOR, T., PEREZ SOLER, R., KUDELKA, A. P., KAVANAGH, J. J., LOPEZ BERESTEIN, G., and KHOKHAR, A., Clinical Cancer Research, 1 999, 5, 334.
  • Ability of doxorubicin-loaded nanoparticles to overcome multidrug resistance of tumor cells after their capture by macrophages. Sox, C. P n -UBERNET, C., BARRATT, G., NEMATI, F., APPEL, M., BENITA, S., and COUVREUR, P., Pharmaceutical Research, 1999, 16, 1710–1716.
  • Actin-dependent pigment granule motility and retrograde movement of surface-attached microspheres in isolated retinal pigment epithelial cells. BASCIANO, P. A
  • DEACON, S., SELLERS, J. R., and KING SMITH, C., Molecular Biology of the Cell, 1999, 10, 797.
  • Activity of doxorubicin covalently bound to a novel human serum albumin microcapsule. EATOCK, M., CHURCH, N., HARRIS, R., ANGERSON, W., MCARDLE, C., FRENCH, R., and TWELVES, C., Investigational New Drugs, 1999, 17, 111–120.
  • Adjuvant therapy for melanoma in dogs: Results of randomized clinical trials using surgery, liposome-encapsulated muramyl tripeptide, and granulocyte macrophage colony-stimulating factor. MACEWEN, E. G., KURZMAN, I. D., VAIL, D. M., DUBIELZIG, R. R., EVERLITH, K., MADEWELL, B. R., RODRIGUEZ, C. 0., PHILLIPS, B., ZWAHLEN, C. H., OBRADOVICH, J., ROSENTHAL, R. C., Fox, L. E., ROSENBERG, M., HENRY, C., and FIDEL, J., Clinical Cancer Research, 1999, 5, 42494258.
  • Adsorption and encapsulation of fluorescent probes in nanoparticles. MAKAROVA, 0. V., OSTAN, A. E., MIYOSHI, H., NORRIS, J. R., and MEISEL, D., Journal of Physical Chemistry B, 1999, 103, 9080–9084.
  • Ag-Mn nanoparticles: Three-dimensional finite size effect of the spin glass state. EDERTH, J., HOEL, A., JOHANSSON, C. I., KISS, L. B., OLSSON, E., GRANQVIST, C. G., and NORDBLAD, P., Journal of Applied Physics, 1 999, 86, 6571-6575.
  • AIDS-related Kaposi's sarcoma: A phase II study of liposomal doxorubicin. CHEUNG, T. W., RLMICK, S. C., AZARNIA, N., PROPER, J. A., BARRUECO, J. R., and DEZUBE, B. J., Clinical Cancer Research, 1999, 5, 3432–3437.
  • An Au nanoparticle/bisbipyridiniuna cyclophane-functionalized ion sensitive field-effect transistor for the sensing of adrenaline. KHARITONOV, A. B., SHIPWAY, A. N., and WILL \ IR, I., Analytical Chemistry, 1999, 71, 5441–5443.
  • An infrared reflectance spectroscopic study of a pH-tunable network of nanoparticles linked by hydrogen bonding. ZHENG, W. X., MAYE, M. M., LEIBOWITZ, F. L., and ZHONG, C. J., Analyst, 1999, 125, 17–20.
  • An investigation into the release of cefuroxitne axetil from taste-masked stearic acid microspheres-Part 1: The influence of the dissolution medium on the drug release profile and the physical integrity of the microspheres. ROBSON, H. J., CRAIG, D. Q. M., and DEUTSCH, D., International Journal of Pharmaceutics, 1999, 190, 183–192.
  • Analytical performance of microparticle enzyme immunoassay and HPLC-Tandem mass spectrometry in the determination of sirolimus in whole blood. SALm, P., TAYLOR, P. J., and 1311.1,ANS, P. I., Clinical Chemistry, 1999, 45, 2278–2280.
  • Antigen-specific, IgE-selective unresponsiveness induced by antigen-liposome conjugates—Comparison of four different conjugation methods for the coupling of antigen to liposome. NAKANO, Y., MORI, M., NISHINOHARA, S., TAKITA, Y., NAITO, S., HORINO, A., KATO, H., TANEICHI, M., Am, Y., SUZAKI, Y., KOMURO, K., and UCHIDA, T., International Archives of Allergy and Immunology, 1999, 120, 199–208.
  • Antitumor activity of Herceptin(R) in combination with STEALTH(R) liposomal cisplatin or nonliposomal cisplatin in a HER2 positive human breast cancer model. COLBERN, G. T., HILLER, A. J., MUSTERER, R. S., WORKING, P. K., and HENDERSON, I. C., Journal of Inorganic Biochemistry, 1999, 77, 117–120.
  • Apoptotic induction of radioresistant malignant glial tumour cells exhibiting mtp53 after combined adxn. of liposomal plasmid wtp53cDNA gene of PC1VIV-Neo-Bam vector and radiotherapy. GIANNIOS, J., and VOUMVOURAKIS, K., Clinical Cancer Research, 1999, 5, 511.
  • Apoptotic induction via CPP32/caspasse-3 pathway of chemoresistant HCC exhibiting MRP-2 and EGFR after treatment with humanized anti-EGFR mAb fusogenic liposomal vinorelbine. GIANNIOS, J., Clinical Cancer Research, 1999, 5, 81.
  • Archaeosome vaccine adjuvants induce strong humoral, cell-mediated, and memory responses: Comparison to conventional liposomes and alum. KRISHNAN, L., n ICAIRE, C. J., PATEL, G. B., and SPROTT, G. D., Infection and Immunity, 2000, 68, 54–63.
  • Artificial cell microcapsules containing genetically engineered E-coli DH5 cells for in-vitro lowering of plasma potassium, phosphate, magnesium, sodium, chloride, uric acid, cholesterol, and creatinine: A preliminary report. PRAKASH, S., and CHANG, T. M. S., Artificial Cells Blood Substitutes and Immobilization Biotechnology, 1999, 27, 475–481.
  • Asymmetric membrane distribution of phosphatidylserine in different liposomal prepara-tions. WIELAND, S., SCHUBERT, R., and PESCHKA SUSS, R., Journal of Liposome Research, 1999, 9, 477–489.
  • Augmented shear-induced platelet aggregation and platelet-derived microparticle forrna-tion after major upper abdominal surgery. IKEDA, M., IWAMOTO, S., KAWASAKI, T., and IKEDA, Y., Blood, 1999, 94, 3442.
  • Automation of the use of fluorescent microspheres for the determination of blood flow. THEIN, E., RAAB, S., HARRIS, A. G., and MESSMER, K., Computer Methods and Programs in Biomedicine, 2000, 61, 11–21.
  • Behavior of 3T3 fibroblast in the presence of liposomes or blood fibrin clot in a low-serum medium containing rhbFGF. WANG, Y. F., 1-1 -ARA, M., YANG, Q., DAI, Y., Cul, Y., MIYAKE, J., and LIN, J., Molecular Biology of the Cell, 1999, 10, 2019.
  • Bile and bile-salts modulate liposomal-mediated oligonucleotide transfection, with enhance-ment by sodium taurocholate. SHEIKH, M., SELDEN, C., MCCLOSKEY, P., and HODGSON, H. J., Hepatology, 1999, 30, 724.
  • Biodegradable bromocryptine mesylate microspheres prepared by a solvent evaporation technique II. Suitability for brain and hypophysis delivery. ARICA, R 1-4. -S, H. -., -ARGON, M. F., ACIKGOZ, B., and HINCAL, A. A., STP Pharma Sciences, 1999, 9, 447–455.
  • Biophysical characterisation of liposomal delivery systems for lipophilic drugs: Cyclosporin A as an example. FAHR, A., and REITER, G., Cellular & Molecular Biology Letters, 1999,4, 611–623.
  • Biophysical state of liposomes modulates vasoactive intestinal peptide vasodilation in vivo. IKEZAKI, H., ONYUKSEL, H., AKHTER, S. R., PATEL, M., and RUBINSTEIN, I., American Journal of Respiratory and Critical Care Medicine, 1999, 159, A283.
  • Blood flow distributions by microsphere deposition methods. PRINZEN, F. W., and BASSINGTHWAIGHTE, J. B., Cardiovascular Research, 2000, 45, 13–21.
  • Bupivacaine release from a novel liposomal formulation: Effect of lipid composition and temperature. GRANT, G. J., Anesthesiology, 1999, 91, A891.
  • Butyrylcholinesterase formulated in liposomes. SCHUMACHER, 1- A -RAD, A., and MARGALIT, R., Biotechnology and Applied Biochemistry, 1999, 30, 225–230.
  • Calcein permeability of liposomes mediated by type A botulinum neurotoxin and its light and heavy chains. Fu, F. N., and SINGH, B. R., Journal of Protein Chemistry, 1999, 18, 701-707. Capture of charge carriers at the silica nanoparticle-water interface. SCHATZ, T., Cook, A. R., and MEISEL, D., Journal of Physical Chemistry B, 1999, 103, 10209–10213.
  • Carbon nanocage structures formed by one-dimensional self-organization of gold nano-particles. Oxu, T., and SUGANUMA, K., Chemical Communications, 1999, 23, 1359-7345. Carbon-coated Fe-Co(C) nanocapsules prepared by arc discharge in methane. DONG, X. L., ZHANG, Z. D., JIN, S. R., and KIM, B. K., Journal of Applied Physics, 1999, 86, 6701–6706.
  • Cellular uptake of liposomal daunorubicin and the induction of apoptosis. -RAY, A., LANDFAIR, D. J., and WILES, M. E., Drug Delivery, 1999, 6, 213–226.
  • Changes in cytokine mRNA levels in experimental corneal allografts after local clodronate-liposome treatment. TORRES, P. F., SLEGERS, T. P. A. M., PEEK, R., VAN ROOIJEN, N., VAN DER GAAG, R., KIJLSTRA, A., and DE VOS, A. F., Investigatim Ophthalmology & Visual Science, 1999, 40, 3194–3201.
  • Charge transfer emission in cournarin 343 sensitized TiO2 nanoparticle: A direct meas-urement of back electron transfer. GHosH, H. N., Journal of Physical Chemistry B, 1999, 103, 10382–10387.
  • Chemisorption effects on colloidal lead nanoparticles. HENGLEIN, A., Journal of Physical Chemistry B, 1999, 103, 9302–9305.
  • Chemosensitization of tumor cells by systemically delivered, ligand-directed, cationic liposome mediated wtp53 gene therapy. Xu, L., TANG, W. H., PIROLLO, K. F., XIANG, L. M., ULIcK, D., and CHANG, E. H., Clinical Cancer Research, 1999, 5, 535.
  • Chitosan and chondroitin microspheres for oral-administration controlled release of meto-clopramide. GANZA GONZALEZ, A., ANGUIANO IGEA, S., OTERO ESPINAR, F. J., and MENDEZ, J. B., European Journal of Pharmaceutics and Biopharmaceutks, 1999, 48, 149–155.
  • Cholesteryl butyrate in solid lipid nanospheres as an alternative approach for butyric acid delivery. PELLIZZARO, C., CORADINI, D., MOREL, S., UGAZIO, E., GASCO, M. R., and DAIDONE, M. G., Anticancer Research, 1999, 19, 3921–3925.
  • Circadian phase-dependent antinociceptive reaction in mice determined by the hot-plate test and the tail-flick test after intravenous injection of dalargin-loaded nanoparticles. RAMGE, P., KREUTER, J., and LEMMER, B., Chronobiology International, 1999, 16, 767–777.
  • Clinical and experimental study on regional administration of phosphorus-32 glass micro-spheres in treating hepatic carcinoma. LL L., JIANG, Z., TENG, G. J., SONG, J. Z., ZHANG, D. S., Guo, Q. M., FANG, W., HE, S. C., and Guo, J. H., World Journal of Gastroenterology, 1999, 5, 492–505.
  • Clinical pharmacokinetics of liposomal lurtotecan (NX211) in whole blood, plasma and urine. KEHRER, D., Bos, A., SPARREBOOM, A., Loos, W., HAMILTON, M., PTASZYNSKI, M., DE VRIES, E., and VERWEIJ, J., Clinical Cancer Research, 1999, 5, 337.
  • Cobalt nanoparticle forrnation in the pores of hyper-cross-linked polystyrene: Control of nanoparticle growth and morphology. SIDOROV, S. N., BRONSTEIN,n -AVANKOV, V. A., TSYURUPA, M. P., SOLODOVNIKOV, S. P., VALETSKY, P. M., WILDER, E. A., and SPONTAK, R. J., Chemistry of Materials, 1999, 11, 3210–3215.
  • Colloidal stability and drug incorporation aspects of micellar-like PLA-PEG nanoparticles. RILEY, T., GOVENDER, T., STOLNIK, S., XIONG, C. D., GARNETT, M. C., ILLUM, L., and DAVIS, S. S., Colloids and Surfaces B—Biointerfaces, 1999, 16, 147–159.
  • Combinations of topotecan and liposomal daunorubicin (Daunoxome) in refractory acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). GILES, F F- . -ANTARHAN, H. M., CORTES, J. E., KOLLER, C., THOMAS, D., O'BRIEN, S. M., ESTEY, E., and BERAN, M., Blood, 1999, 94, 4233.
  • Combined effects of plant extracts and xenobiotics on liposomal lipid peroxidation. Part 1. Marigold extract-ciprofloxacin/pyralene. POPOVIC, M., KAURINOVIC, B., MIMICA DUKIC, N., VOJINOVIC MILORADOV, M., and CUPIC, V., Oxidation Communications, 1999, 22, 487–494.
  • Commentary: Lipids and liposomes can do more than carry drugs: Phosphatidylserine as a regulator of blood coagulation. LENTZ, B. R., Journal of Liposome Research, 1999, 9, R9–R15.
  • Comparative efficacy of liposomal FK 506 with FK 506 (tacrolimus) with and without anti-CD4/CD8 monoclonal antibodies. MOATT, S. D., MCALISTER, V., CALNE, R. Y., and METCALFE, S. M., Transplantation Proceedings, 1999, 31, 2754.
  • Comparison between microspheres (MS) and PET imaging of pulmonary perfusion(Q) distri-bution. VENEGAS, J. G., GLENNY, R., HARRIS, R. S., CALL, D., LAYFIELD, J. D. H., and GALLETTI, G. G., American Journal of Respiratory and Critical Care Medicine, 1999, 159, A577.
  • Comparison of the effects of liposomal amphotericin B, and conventional amphotericin B on propafenone metabolism and hepatic cytochrome P-450 in rats. INSELMANN, G., VOLKMANN, A., and HEIDEMANN, H. T., Antimicrobial Agents and Chemotherapy, 2000, 44, 131–133.
  • Comparison of the safety profiles of PLA(50) and Me.PEG-PLA(50) nanoparticles after single dose intravenous administration to rat. PLARD, J. P., and BAZILE, D., Colloids and Surfaces B—Biointerfaces, 1999, 16, 173–183.
  • Complete resolution of angiosarcoma of the scalp with liposomal daunorubicin and radio-therapy. LANKESTER, K. J., BROWN, R. S. D., and SPITTLE, M. F., Clinical Oncology, 1999, 11, 208–210.
  • Concurrent radiotherapy and chemotherapy with topotecan and stealth liposomal doxor-ubicin for the treatment of locally advanced pelvic tumours. KOUKOURAKIS, M. I., CHALDEOPOULOS, D., LYRARAKI, E., and VARVERIS, C., European Journal of Cancer, 1999, 35, 355.
  • Conformation of ethylhexanoate stabilizer on the surface of CdS nanoparticles. DIAZ, D., RIVERA, M., Ni, T., RODRIGUEZ, J. C., GASTILLO BLUM, S. E., NAGESHA, D., ROBLES, J., ALVAREZ FREGOSO, 0. J., and KOTOV, N. A., Journal of Physical Chemistry B, 1999, 103, 9854–9858.
  • Controlled release behavior of prodrugs based on the biodegradable poly(L-glutamic acid) microspheres. KIM, K. S., KIM, T. K., and GRAHAM, N. B., Polymer Journal, 1999, 31, 813–816.
  • Coupled synthesis and self-assembly of nanoparticles to give structures with controlled organization. Li, M., SCHNABLEGGER, H., and MANN, S., Nature, 1999, 402, 393–395.
  • Covalent attachment of gold nanoparticles onto the thiol-terminated surface through Au-S bonding LA-Chinese. Hu, R. S., Liu, S. T., ZHu, T., Liu, Z. F., HUANG, X. H., and Hi_ AN(., H. Z., Acta Physko-Chimka Sinka, 1999, 15, 961–965.
  • Covalent immobilization of alpha-amylase onto poly(2-hydroxyethyl methacrylate) and poly(styrene-2-hydroxyethy1 methacrylate) microspheres and the effect of Ca2+ ions on the enzyme activity. TUMTURK, H., AKSOY, S., and HASIRCI, N., Food Chemistry, 2000, 68, 259–266.
  • Cultured epidermal keratinocytes on a microspherical transport system are feasible to reconstitute the epidermis in full-thiclmess wounds. VOIGT, M., SCHAUER, M., SCHAEFER, D. J., ANDREE, C., HORCH, R., and STARK, G. B., Tissue Engineering, 1999, 5, 563–572.
  • Cycle life and utilization studies on cobalt microencapsulated AB(5) type metal hydride. DURAIRAJAN, A., HARAN, B. S., POPOV, B. N., and WHITE, R. E., Journal of Power Sources, 1999, 83, 114–120.
  • Cyclophosphamide, liposomal doxorubicin and dexamethasone (CLAD) is safe and effica-cious in multiple rnyelorna. SZELENYI, H., SIEHL, J., MENSSEN, H. D., THIEL, E., and KEILHOLZ, U., European Journal of Cancer, 1999, 35, 1359.
  • Deconvolution analysis for absorption and metabolism of aspirin in microcapsules. Wu, X. N., YAMASHITA, F., and HASHIDA, M., Biological & Pharmaceutical Bulletin, 1999, 22, 1212–1216.
  • Dependence of fluorescence lifetimes of Y203:Eu3+ nanoparticles on the surrounding medium. MELTZER, R. S., FEOFILOV, S. P., TISSUE, B., and YUAN, H. B., Physical Review B—Condensed Matter, 1999, 60, 14012–14015.
  • Derivatized, swellable polymer microspheres for chemical transduction. SEITZ, W. R., ROONEY, M. T. V., MIELE, E. W., WANG, H. M., KAVAL, N., ZHANG, L., DOHERTY, S., MILDE, S., and LENDA, J., Analytka Chimica Acta, 1999, 400, 55–64.
  • Determination of particle sizes and crystalline phases on colloidal silicon nanoparticle suspensions. Scum.; S. M., and HOFMANN, H., Journal of Materials Science & Technology, 1999, 15, 548–550.
  • Development of a freeze-dried formulation of insulin-loaded chitosan nanoparticles intended for nasal administration. FERNANDEZ URRUSUNO, R., ROMANI, D., CALVO, P., VILA JATO, J. L., and ALONSO, M. J., STP Pharma Sciences, 1999, 9, 429–436.
  • Development of a microparticle-enhanced nephelometric immunoassay for quantitation of human lysozyrne in pleural effusion and plasma. CABALLERO, M., RUIZ, R., DE PRADO, M. M., SECO, M., BORQUE, L., and ESCANERO, J. F., Journal of Clinical Laboratory Analysis, 1999, 13, 301–307.
  • Development of sustained-release ibuprofen microspheres using solvent evaporation tech-nique. ARIDA, A. I., AMRO, B., JAGHBIR, M., EL ALEM, M., SABRI, R., and ABU ZEID, R., Archiv der Pharmazie, 1999, 332, 405–407.
  • Differing susceptibility of echocardiographic contrast agents to adverse effects of biologic factors: Multicenter, videodensitometric comparison of octafluoropropane-filled microspheres with air-filled microspheres for left ventricular opacifi. HAUSNEROVA, E., GOTTDIENER, J. S., GOULD, J. J., PEZZULLO, J. C., CALLAHAN, J.D., COHEN, J. L., BRUNS, D. E., KUVELAS, M. T., WEST, H. E., and DITTRICH, H. C., Journal of the American Society of Echocardiography, 1999, 12, 957–966.
  • Direct comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: Is surface coating with polyethylene glycol beneficial? HONG, R., HUANG, C. J., TSENG, Y. L., PANG, V. F., CHEN, S. T., Liu, J. J., and CHANG, F. H., Clinical Cancer Research, 1999, 5, 3645–3652.
  • Dispersed molecular aggregates. 1. Synthesis and characterization of nanoparticles of Cu-2[Fe(CN)(6)] in H20/A0T/n-heptane water-in-oil microemulsion media. Moutax, S. P., DE, G. C., PANDA, A. K., BHOWMIK, B. B., and Dv', A. R., Langmuir, 1999, 15, 8361–8367.
  • Down-regulation of IGF1-R by liposomal antisense oligodeoxynucleotides activates a cas-pase-3 pathway inducing massive apoptosis D2 stage in ductal adenocarcinoma of pancreas (DAP). GIANNIOS, J., Cancer Gene Therapy, 1999, 6, PD24.
  • Down-regulation of mammalian 3-hydroxy-3-methylglutaryl coenzyme A reductase activity with highly purified liposomal cholesterol. PLEMENITAS, A., and WATSON, J. A., European Journal of Biochemistry, 1999, 266, 317–326.
  • Drug-delivery system based on core-shell-type nanoparticles composed of poly(gamma-benzyl-L-glutamate) and poly(ethylene oxide). NAH, J. W., JEONG, Y. I., CHo, C. S., and KIM, S. I., Journal of Applied Polymer Science, 2000, 75, 1115–1126.
  • Dynamics of action of bisphenol as radical-scavenging antioxidant against lipid peroxidation in solution and liposomal membranes. NISHINO, K., NocucHI, N., and Nix', E., Free Radical Research, 1999, 31, 535–548.
  • Effect of microencapsulation on the efficacy of deer and rabbit repellent Daphne. Box, B., KOSIR, I., KNEZ, E., KUKOVIC, M., SKERLAVAJ, V., and SKVARC, A., International Journal of Pest Management, 1999, 45, 297–303.
  • Effect of surface state properties of TiO2 nanoparticle film on its photocatalytic activity LA-Chinese. CAO, Y. A., DING, L., MA, Y., GUAN, Z. S., XIE, T. F., ZHANG, X. T., Wu, Z. Y., BAI, Y. B., LI, T. J., YAO, J. N., and Wu, Y., Chemical Journal of Chinese Universities—Chinese, 1999, 20, 1787–1789.
  • Effect of unidirectional anisotropy on the ferromagnetic resonance in ferrite nanoparticles. SHILOV, V. P., RAIKHER, Y. L., BACRI, J. C., GAZEAU, F., and PERZYNSKI, R., Physical Review B—Condensed Matter, 1999, 60, 11902–11905.
  • Effects of protective colloids upon properties of ethylcellulose microcapsules prepared from various non-solvent addition methods. CHIU, H. C., Lo, C. L., WANG, F. Y., and Hsu, J., Journal of the Chinese Institute of Chemical Engineers, 1999, 30, 491–499.
  • Effects of thermal treatments on structural and magnetic properties of acicular alpha-Fe203 nanoparticles. SUBER, L., FIORANI, D., IMPERATORI, P., FOGLIA, S., MONTONE, A., and ZYSLER, R., Nanostructured Materials, 1999, 11, 797–803.
  • Elastic properties of nanoparticle chain aggregates of Ti02, A1203, and Fe203 generated by laser ablation. OGAWA, K., VOGT, T., ULLMANN, M., JOHNSON, S., and FRIEDLANDER, S. K., Journal of Applied Physics, 2000,87, 63–73.
  • Electrochemical quantized capacitance charging of surface ensembles of gold nanopar-tides. CHEN, S. W., and MURRAY, R. W., Journal of Physical Chemistry B, 1999, 103, 9996–10000.
  • Electrochromistn of nanoparticulate-doped metal oxides: optical and material properties. COLEMAN, J. P., FREEMAN, J. J., MADHUKAR, P., and WAGENKNECHT, J. H., Displays, 1999, 20, 145–154.
  • Electron dynamics in silver nanoparticles: Comparison between thin films and glass embedded nanoparticles. HALTE, V., GUILLE, J., MERLE, J. C., PERAKIS, I., and BIGOT, J. Y., Physical Review B—Condensed Matter, 1999, 60, 11738–11746.
  • Electron-beam induced growth of Cu nanoparticles in silica glass matrix. ITO, Y., JAIN, H., and WILLIAMS, D. B., Applied Physics Letters, 1999, 75, 3793–3795.
  • Enantioselective borane reduction of ketones with oxazaborolidines boron-bound to nickel boride nanoparticles. MOLVINGER, K., LOPEZ, M., and COURT, J., Tetrahedron Letters, 1999, 40, 8375–8378.
  • Enhanced platelet activation and platelet microparticles in patients with obstructive sleep apnea syndrome. GEISER, T., BUCK, F., MEYER, B. J., HAEBERLI, A., BEER, J. H., and GUGGER, M., American Journal of Respiratory and Critical Care Medicine, 1999, 159, A528.
  • Enhancement of platinum-drug cytotoxicity in a human head, and neck squamous cell carcinoma line and its platinum-resistant variant by liposomal amphotericin band phospholipase A2-1I. FERGUSON, P. J., CURRIE, C., and VINCENT, M. D., Drug Metabolism and Disposition, 1999, 27, 1399–1405.
  • Enhancement of the phase transition permeability of DPPC liposomes by incorporation of MPPC: A new temperature-sensitive liposome for use with mild hyperthermia. ANYARAMBHATLA, G. R., and NEEDHAM, D. Journal of Liposome Research, 1999, 9, 491–506.
  • Etch-eroded fiber coupler for whispering-gallery-mode excitation in high-Q silica micro-spheres. LAINE, J. P., LITTLE, B. E., and HAUS, H. A., IEEE Photonics Technology Letters, 1999, 11, 1429–1430.
  • Evaluation of effect of charge and lipid coating on ability of 60-nm nanoparticles to cross an in vitro model of the blood-brain barrier. FENART, L., CASANOVA, A., DEHOUCK, B., DUHEM, C., SLUPEK, S., CECCHELLI, R., and BETBEDER, D., Journal of Pharmacology and Experimental Therapeutics, 1999, 291, 1017–1022.
  • Evaluation of the in-vivo activity, and toxicity of amarogentin, an antileishrnanial agent, in both liposomal, and niosomal forms. MEDDA, S., MUKHOPADHYAY, S., and BASU, M. K., Journal of Antimicrobial Chemotherapy, 1999, 44, 791–794.
  • Evolution of the morphological structure of a two-dimensional cluster obtained with a linear microparticle trajectory in the diffusion-limited aggregation regime. BERG, D. B., Technical Physics Letters, 1999, 25, 962–964.
  • Fabrication and optical properties of two-dimensional ordered arrays of silica microspheres. YAMASAKI, T., and TSUTSUI, T., Japanese Journal of Applied Physics Part 1—Regular Papers, Short Notes & Review Papers, 1999, 38, 5916–5921.
  • Fabrication of ordered two-dimensional arrays of micro- and nanoparticles using patterned self-assembled monolayers as templates. QIN, D., XIA, Y. N., Xu, B., YANG, H., ZHU, C., and WHITESIDES, G. M., Advanced Materials, 1999, 11, 1433–1437.
  • Femtosecond studies of coherent acoustic phonons in gold nanoparticles embedded in TiO2 thin films. QIAN, W., LIN, L., DENG, Y. J., XIA, Z. J., Zou, Y. H., and WONG, G. K. L., Journal of Applied Physics, 2000, 87, 612–614.
  • Fetal gene transfer by transuterine injection of cationic liposome-DNA complexes. GAENSLER, K. M. L., Tu, G. H., BRUCH, S., LIGGITT, D., LIPSHUTZ, G. S., METKUS, A., HARRISON, M., HEATH, T. D., and DEBS, R. J., Nature Biotechnology, 1999, 17, 1188–1192.
  • Field emission from a new form of thin film amorphous carbon having nanoparticle inclusions and carbon nanotubes. AMARATUNGA, G. A. J., BAXENDALE, M., RUPESINGHE, N., ALEXANDROU, I., CHHOWALLA, M., BUTLER, T., MUNINDRADASA, A., KILEY, C. J., ZHANG, L., and SAKI, T., New Diamond and Frontier Carbon Technology, 1999, 9, 31–51.
  • Flow cytometric, phase-resolved fluorescence measurement of propidium iodide uptake in macrophages containing phagocytized. fluorescent microspheres. STEINKAMP, J. A., VALDEZ, Y. E., and LEHNERT, B. E., Cytornetry, 2000, 39, 45–55.
  • Fluorescence correlation spectroscopy analysis of the hydrophobic interactions of protein 4.1 — with phosphatidyl serine liposomes. TAKAKUWA, Y., PACK, C. a -N A, IC1VEANNO, S., ITO, E., and KINJO, M., Biophysical Chemistry, 1999, 82, 149–155.
  • Fluorescence image of a single molecule in a microsphere: model. HILL, S. C., NACHMAN, P., ARNOLD, S., RAMSEY, T. M., and BARNES, M. D., Journal of the Optical Society of America B—Optical Physics, 1999, 16, 1868–1873.
  • Fluorescence spectroscopy studies of the association of membrane and soluble forms of chromaffin granule dopamine-beta-monooxygenase to bipolar phospholipid liposomes and micelles. POGOSYAN, A. G., BOYAJIAN, A. S., MAILYAN, K. R., and AIVAZYAN, V. A., Biologicheskk Membrany, 1999, 16, 534–540.
  • Formation of colloidal silver nanoparticles: Capping action of citrate. HENGLEIN, A., and GIERSIG, M., Journal of Physical Chemistry B, 1999, 103, 9533–9539.
  • Formation of one-dimensional arrays of gold nanoparticles with DNALA-Japanese. YONEZAWA, T., ONOUE, S., and KUNITAKE, T., Kobunshi Ronbunshu, 1999, 56, 855–859.
  • Formation of ordered structures from metal nanoparticles in the surface layer of glassy polymer. RUDOY, V. M., YAMINSKII, I. V., DEMENTEVA, 0. V., and OGAREV, V. A., Colloid Journal, 1999, 61, 800–801.
  • Formation of silver nanoparticles in soda-lime silicate glass by ion implantation near room temperature. STEPANOV, A. L., HOLE, D. E., and TOWNSEND, P. D., Journal of non-Crystalline Solids, 1999, 260, 65–74.
  • Fractionated cyclophosphamide, vincristine, liposomal daunorubicin (daunoXome), dexa-methasone (hyperCVXD) regimen in Richter's syndrome. DABAJA, B. S., -ANTARJIAN, H. M., CORTES, J. E., THOMAS, D. A., SARRIS, A., O'BRIEN, S. M., KEATING, M. J., and GILES, F. J., Blood, 1999, 94, 4370. G-C.SF is of little benefit as secondary prophylaxis with liposomal anthracycline in Illy-associated Kaposi's sarcoma. MORGAN, J., CLARK, S., SMITH, E., FIFE, K., and BOWER, M., European Journal of Cancer, 1999, 35, 1537.
  • Gene transfection using biodegradable nanospheres: results in tissue culture and a rat osteotomy model. LABHASETWAR, V., BONADIO, J., GOLDSTEIN, S. A., and LEVY, J. R., Colloids and Surfaces B—Biointerfaces, 1999, 16, 281–290.
  • Generation of platelet-derived microparticles and procoagulant activity by heparin-induced thrombocytopenia IgG/serum and other IgG platelet agonists: a comparison with standard platelet agonists. WARKENTIN, T. E., and SHEPPARD, J. I., Platelets, 1999, 10, 319–326.
  • Globular carbohydrate macromolecule 'sugar balls' IV. Synthesis of dendritic nanocapsules with molecular recognition sites on periphery. TSUTSUMIUCHI, K., Aoi, K., and OKADA, M., Polymer Journal, 1999, 31, 935–941.
  • Gold-nanoparticle/bis-bipyridiniurn cyclophane-functionalized ion-sensitive field-effect transistors: Novel assemblies for the sensing of neurotransmitters. KHARITONOV, A. B., SHIPWAY, A. N., KATZ, E., and WILLNER, I., Reviews in Analytical Chemistry, 1999, 18, 255–260.
  • Graft copolymers having hydrophobic backbone and hydrophilic branches XXI. Preparation of galactose surface-accumulated polystyrene nanospheres and their interaction with lectin. UCHIDA, T., SERIZAWA, T., and AKASHI, M., Polymer Journal, 1999, 31, 970–973.
  • Growth of zeolite KS01 on calcined kaolin microspheres. Xu, M. C., CHENG, M. J., LILT, X. M., TAN, D. L., and BAO, X. H., Journal of Materials Chemistry, 1999, 9, 2965–2966.
  • Growth response in lambs injected with a long acting microencapsulated Vitamin B- 12.
  • GRACE, N. D., and SINCLAIR, G. R., New Zealand Veterinary Journal, 1999, 47, 213-214. Heat-insulating corundum ceramics based on hollow microspheres. VLASOV, A. S., POLYAK, B. I., and POSTNIKOV, S. A., Glass and Ceramics, 1999, 56, 81–82.
  • High-performance liquid chromatographic determination of liposomal nystatin in plasma and tissues for pharmacokinetic and tissue distribution studies. GROLL, A H -ICKIENE, D., WERNER, K., PISCITELLI, S. C., and WALSH, T. J., Journal of Chromatography B, 1999, 735, 51–62.
  • Highly loaded nanoparticulate carrier using an hydrophobic antisense oligonucleotide complex. BERTON, M., ALLEMANN, E., STEIN, C. A., and GURNY, R., European Journal of Pharmaceutical Sciences, 1999, 9, 163–170.
  • Highly luminescent thin films from alternating deposition of CdTe nanoparticles and polycations. LESSER, C., GAO, M., and KIRSTEIN, S., Materials Science & Engineering C-Biomimetic and Supramolecular Systems, 1999, 159–162.
  • Hydrophilic magnetic polymer latexes. 2. Encapsulation of adsorbed iron oxide nano-particles. SAUZEDDE, F., ELAISSARI, A., and PICHOT, C., Colloid and Polymer Science, 1999, 277, 1041–1050.
  • Immune implications of cytostatics loaded in drug carriers of second generation. Nanoparticles. BALACESCU, 0., BERINDAN, I., RISCA, R., and NEAGOE, E., European Journal of Cancer, 1999, 35, 771.
  • Immuno-ultrastructural characterization of platelet-derived microparticles. TALAB, A. T. H., MASSE, J. M., and CRAMER, E. M., Blood, 1999, 94, 3456.
  • Immunosensors based on supported lipid membranes, protein films and liposomes modified by antibodies. HIANIK, T., SNEJDARKOVA, M., SOKOLIKOVA, L., MESZAR, E., KRIVANEK, R., TVAROZEK, V., NOVOTNY, I., and WANG, J., Sensors and Actuators B-Chemical, 1999, 57, 201–212.
  • Improvement of gas exchange after intratracheal administration of liposome encapsulated hemoglobin (LEH) in two different types of experimental respiratory distress syn-drome models. TAJIMA, A 1-1 -ORINOUCHI, H., and KOBAYASHI, K., American Journal of Respiratory and Critical Care Medicine, 1999, 159, A380.
  • In vitro cellular accumulation, and cytotoxicity of liposomal, and conventional formulations of daunorubicin and doxorubicin in resistant K562 cells. WANG, Y. Y., EKSBORG, S., LEWENSOHN, R., LINDBERG, A., and LILIEMARK, E., Anti-Cancer Drugs, 1999, 10, 921–928.
  • In vivo gene transfer of an extracellular domain of platelet-derived growth factor beta receptor by the HVJ-liposome method ameliorates bleomycin-induced pulmonary fibrosis. YOSHIDA, M., SAKUMA MOCHIZUKI, J., ABE, K., ARAI, T., MORI, M., GOYA, S., MATSUOKA, H., HAYASHI, S., KANEDA, Y., and KISHIMOTO, T., Biochemical and Biophysical Research Communications, 1999, 265, 503–508.
  • In vivo molecular imaging of tissue factor in carotid arteries with a one-step ligand conjugated acoustic nanoparticle. LANZA, G. Al- - A BENDSCHEIN, D. R., HALL, C. S., SCHERRER, D. E., SCOTT, M. J., MARSH, J. N., MILLER, J. G., and W ICKLINE, S. A., Circulation, 1999, 100, 367.
  • Incorporation of magnetic nanoparticles in new hybrid networks based on heteropolyanions and polyacrylamide. MAYER, C. R., CABUIL, V., LALOT, T., and THOUVENOT, R., Angewandte Chemie-International Edition, 1999, 38, 3672–3675.
  • Increased intracellular drug accumulation and complete chemosensitization achieved in multidrug-resistant solid tumors by co-administering valspodar (psc 833) with steri-cally stabilized liposomal doxorubicin. KRISHNA, R., ST LOUIS, M., and MAYER, L. D., International Journal of Cancer, 2000,85, 131–141.
  • Induction of apoptosis in macrophages by cationic liposomes. ARAMAKI, Y., TAKANO, S., and TSUCHIYA, S., FEBS Letters, 1999, 460, 472–476.
  • Induction of cytotoxic T-cell responses following oral immunization with synthetic peptides encapsulated in PLG microparticles. PARTIDOS, C. D., VOHRA, P., JoNEs, D. H., FARRAR, G., and STEWARD, M. W Journal of Controlled Release, 1999, 62, 325–332.
  • Influence of colloid stabilizing agents on interactions between nanoparticles and mucus. DURRER, C., IRACHE, J. M., DUCHENE, D., and PONCHEL, G., STP Pharma Sciences, 1999, 9, 437–'141.
  • Influence of encapsulated enzyme on the surface properties of freeze- dried liposomes in trehalose. BAKAS, L., Colloids and Surfaces B-Biointe rfaces, 2000, 17, 103–109.
  • Influence of surfactants on behavior of dyes in reversed micelles containing AgC1 nanopar-tides. Liu, C. Y., ZHANG, Z. Y., and WANG, C. Y., Journal of Imaging Science and Technology, 1999, 43, 492–497.
  • Inhibition by liposomal cholesterol of Streptococcus pneurnoniae induced lung epithelial cell damage. BERUBE, L. R., ROY, D., VILLENEUVE, N., and JARRELL, H. C., journal of Liposome Research, 1999, 9, 539–549.
  • Initial phase I trial of a new liposome-encapsulated doxorubicin formulation in patients with refractory solid tumors. IZQUIERDO, M. A., BALANA, C., FABREGAT, X., GARCIA, M., MARTINEZ, M., LLORENS, M. A., GIMENO, M., MESIA, R., ROSELL, R., and GERMA, J. R., Clinical Cancer Research, 1999, 5, 330.
  • Interaction of liposomal and polycationic transfection complexes with pulmonary surfactant. ERNST, N., U LRI CH SKOTTER, S S CHMAL IX W. A., RADLER, J., GALNEDER, R., MAYER, E., GERSTING, S., PLANK, C., REINHARDT, D., and ROSENECKER, J., Journal of Gene Medicine, 1999, 1, 331–340.
  • Interfacial charge transfer behaviors of nanoparticulate CdSe thin film electrodes. LIN, Y ZHANG, J. B., YIN, F., and XIAO, X. R., Zeitschrift fur Physikalische Chemk—Internationd Journal of Research in Physical Chemistry & Chemical Physics, 1999, 213, 1–7.
  • Interleukin-12 delivered by biodegradable microspheres promotes the antitumor activity of human peripheral blood lymphocytes in a human head and neck tumor xenograft/ SCID mouse model. KURIAKOSE, M. A., CHEN, F. A., EGILMEZ, N. K., JoNG, Y. S., MATHIOWITZ, E., DE LACURE, M. D., HICKS, W. L., LOREE, T. L., and BANKERT, R. B., Head and Neck—Journal for the Sciences and Specialties of the Head and Neck, 2000, 22, 57–63.
  • Intradendrimer exchange of metal nanoparticles. ZHAO, M. Q., and CROOKS, R. M., Chemistry of Materials, 1999, 11, 3379–3385.
  • Intraocular pharmacokinetics and safety of a humanized monoclonal antibody in rabbits after intravitreal administration of a solution or a PLGA microsphere formulation. MORDENTI, J., THOMSEN, K., LICKO, V., BERLEAU, L., KAHN, J. W., CUTHBERTSON, R. A., DUENAS, E. T., RYAN, A. M., SCHOFIELD, C., BERGER, T. W., MENG, Y. G., and CLELAND, J., Toxicological Sciences, 1999, 52, 101–106.
  • Intravenous cationic liposome endostatin gene therapy for spontaneous canine cancer. MACEWEN, E. G., THAMM, D. H., MEDBERRY, P., ELMSLIE, R. E., and Dow, S. W., Clinical Cancer Research, 1999, 5, 409.
  • Investigation of dynamic Stem layer of liposomes by utilizing the isoelectric point and isoconducting point. MATSUMURA, H., VERBICH, S. V., and DUKHIN, S. S., Colloids and Surfaces A—Physicochemical and Engineering Aspects, 1999, 159, 271–276.
  • Kinetic effect in the size-control of Cc1S nanoparticles. YANG, J. J., ZHANG, S. L., ZHANG, Z. J., Du, Z. L., ZHANG, J., and JIN, Z. S., Science in China Series B—Chemistry, 1999, 42, 631–638.
  • Kinetics of in vitro release of a model nucleoside deoxyuridine from crosslinked insoluble collagen and collagen-gelatin microspheres. CHOWDHURY, D. K., and MITRA, A. K., International Journal of Pharmaceutics, 1999, 193, 113–122.
  • Kupffer cell targeting by intraportal injection of the HVJ-cationic liposome. YOSHIDA, M., UEHARA, T., SUETSUGU, H., Iimuao, Y., YAMAMOTO, N., SHIMAHARA, Y., and YAMAOKA, Y Hepatology, 1999, 30, 714.
  • Laser light-scattering studies of poly(caprolactone-b-ethylene oxide- b-caprolactone) nano-particles and their enzymatic biodegradation. ZHAO, Y., Hu, T. J., Lv, Z., WANG, S. G., and Wu, C., Journal of Polymer Science Part B—Polymer Physics, 1999, 37, 3288–3293.
  • Lectin-mediated transport of nanoparticles across Caco-2 and OK cells. RUSSELL JONES, G. J., VEITCH, H., and ARTHUR, L., International Journal of Pharmaceutics, 1999, 190, 165–174.
  • Ligand-targeted, liposome-mediated p53 gene therapy in combination with radiation or chemotherapy leads to prostate tumor regression. PIROLLO, K. F., XU, L., TANG, W. H., RAIT, A., and CHANG, E. H., Clinical Cancer Research, 1999, 5, 508.
  • Lipid nanospheres containing vitamin A or vitamin E: Evaluation of their stabilities and in vitro skin permeability. KIM, S. Y., and LEE, Y. M., Journal of Industrial and Engineer* Chemistry, 1999, 5, 306–313.
  • Liposomal anticancer drugs as agents to be used in combination with other anticancer agents: Studies on a liposomal formulation with two encapsulated drugs. SAXON, D. N., MAYER, L. D., and BALLY, M. B., Journal of Liposome Research, 1999, 9, 507–522.
  • Liposomal daunorubicin is active and well tolerated in the treatment of multiple myeloma. MOHRBACHER, A. F., GREGORY, S., JUSTICE, G., SCHLUTZ, M., ROBERTS, L., CHEN, D., and GILES, F. J., Blood, 1999, 94, 4624.
  • Liposomal ET-18-0CH3 induces cytochrome c-mediated apoptosis independently of CD95 (APO-1/Fas) signaling. CUVILLIER, O., MAYHEW, E., JANOFF, A. S., and SPIEGEL, S., Blood, 1999, 94, 3583–3592.
  • Liposomal gene transfer of human NOS-2 reduces intimal hyperplasia in rabbit femoral arteries. GROSSER, T., VELT, K., BUERKE, 1VI., IBE, W., LINDEMANN, S., SUBIN, B., and DARIUS, H., Circulation, 1999, 100, 15.
  • Liposome encapsulated daunorubicin doubles anthracycline toxicity in cell lines showing a non-PGP related multidrug resistance. MICHIELI, M., DAMIANI, D., ERMACORA, A., MASOLINI, P., MicHELurn, A., and BACCARANI, M., Haematologica, 1999, 84, 1151–1152.
  • Liposome encapsulation of a soluble recombinant fragment of the respiratory syncytial virus (RSV) G protein enhances immune protection and reduces lung eosinophilia associ-ated with virus challenge. MADER, D., HUANG, Y., WANG, C., FRASER, R., ISSEKUTZ, A. C., STADNYK, A. W., and ANDERSON, R., Vaccine, 2000, 18, 1110–1117.
  • Liposome immunoassay for determination of phenytoin. ZHU, W. Y., CHANG, W. B., and CI, Y. X., Chinese Chemical Letters, 1998, 9, 1035–1038.
  • Liposome-mediated gene transfer into human basal cell carcinoma. HOTTIGER, M. 0., DAM, T. N., NICKOLOFF, B. J., JOHNSON, T. M., and NABEL, G. J., Gene Therapy, 1999, 6, 1929-1935. Liposomes and Wystan Auden. WEISSMANN, G., Journal of Liposome Research, 1999, 9, 552. Liposomes as carriers of radionuclides: From imaging to therapy. KOSTARELOS, K., and EMETZOGLOU, D., Journal of Liposome Research, 1999, 9, 429460.
  • Liposomes for the delivery of nucleotides and oligonucleotides. FATTAL, E., DELATTRE, J., DUBERNET, C., and COUVREUR, P., STP Pharma Sciences, 1999, 9, 383–390.
  • Liposomes in the treatment of infectious diseases. FIELDING, R. M., and LAsic, D. D., Expert Opinion on Therapeutic Patents, 1999, 9, 1679–1688.
  • Liposomes loaded with cystostatic bile acid derivatives, two additive strategies to overcome the resistance to chemotherapy. SERRANO, AT A Pt, 0., -1 XCIAS, R. I., BRAVO, P., CASSIO, D., and MARIN, J. J., Hepatology, 1999, 30, 1506.
  • Low dose of liposomal amphotericin is effective in prevention of oral mucositis following high dose chemotherapy amcn. CINIERI, S., ORLANDO, L., EL TAANI, H., COQUIO, A., PECCATORI, F., COCOROCCHIO, E., FERRUCCI, P. F., SCALAMOGNA, R., AGAZZI, A., PIRAS, A., BERTOLINI, F., and MARTINELLI, G., Blood, 1999, 94, 4862.
  • Luminescence quenching in ZnS nanoparticles due to Fe and Ni doping. BORSE, P. H., DESHMUKH, N., SHINDE, R. F., DATE, S. K., and KULKARNI, S. K., Journal of Materials Science, 1999, 34, 6087–6093.
  • Magnetic conductive liquids: preparation and properties of iron nanoparticles in mercury. DuBois, E., CHEVALET, J., and MASSART, R., Journal of Molecular Liquids, 1999, 83, 243–254.
  • Magnetic field effects on photocurrent responses from modified electrodes with CdS nano-particles. YONEMURA, H., YOSHIDA, M., MIYAKE, S., and YAMADA, S., Electrochemistry, 1999, 67, 1209–1210.
  • Magnetic microsphere and its use in biochemical separation and analysis IA-Chinese. JING, X. Y., Li, R. M., WANG, P., WANG, J., YUAN, Y., and ZHU, G. Y., Chinese Journal of Analytical Chemistry, 1999, 27, 1462–1467.
  • Magnetic nanoparticle relaxation measured by a low-T-c SQUID system. HALLER, A., HARTwIG, S., MATZ, H., LANGE, J., RHEINLANDER, T., KOTITZ, R., WEITSCHIES, W., and TRAHMS, L., Superconductcr Science & Technology, 1999, 12, 956–958.
  • Marked pharmacologically-induced changes in bronchial blood flow distribution using fluorescent microsphere and histological methods. LUCHTEL,BERNARD, S. L.,BOYKIN, J. C., and LAKSHMINARAYAN, S., American Journal of Respiratory and Critical Care Medicine, 1999, 159, A577.
  • Mechanism of a terahertz optical Ken- shutter with a gold nanoparticle system. INOUYE, H., TANAKA, K., TANAHASHI, I., KONDO, Y., and HIRAO, K., Journal of the Physical Society of Japan, 1999, 68, 3810–3812.
  • Mechanism of thiyl radical-catalyzed isomerization of unsaturated fatty acid residues in homogeneous solution and in liposornes. SPRINZ, H., SCHWINN, J., NAUMOV, S., and BREDE, 0., Biochimica et Biophysica Acta—Molecular and Cell Biology of Lipids, 2000, 1483, 91–100.
  • Membrane destabilization assay based on potassium release from liposomes. SILBERSTEIN, A., MIRZABEKOV, T., ANDERSON, W. F., and ROZENBERG, Y., Biochinzica et Biophysica Acta—Biomembranes, 1999, 1461, 103–112.
  • Microencapsulation of human growth hormone within biodegradable polyester micro-spheres: Protein aggregation stability and incomplete release mechanism. Kim, H. K., and PARK, T. G., Biotechnology and Bioengineering, 1999, 65, 659–667.
  • Microsphere tensiometry to measure advancing and receding contact angles on individual particles. ECKE, S., PREUSS, M., and BUTT, H. J., Journal of Adhesion Science and Technology, 1999, 13, 1181–1191.
  • Microsphere-mediated targeted gene therapy of solid tumors. DASS, C. R., and BURTON, M. A., Drug Therapy, 1999, 6, 2 43–252.
  • Microstructure and magnetic behavior of carbon-coated Co nanoparticles studied by nuclear magnetic resonance. ZHANG, Y. D., BUDNICK, J. I., HINES, W. A., MAJETICH, S. A., and KIRKPATRICK, E. M., Applied Physics Letters, 2000, 76, 94–96.
  • Milk fat microencapsulation using whey proteins. KEOGH, M. K., and O'KENNEDY, B. T., International Dairy Journal, 1999, 9, 657–663.
  • Molecular and physicochemical aspects of the interactions of the tuberculostatics ofloxacin and rifampicin with liposomal bilayers: a P-31-N1VIR and DSC study. BERMUDEZ, M., MARTINEZ, E., MORA, M., SAGRISTA, M. L., and DE MADARIAGA, M. A., Colloids and Surfaces A-Physicochemical and Engineering Aspects, 1999, 158, 59–66.
  • Molecular localization and state of amphotericin B in PEG liposomes. MORIBE, K., MARUYAMA, K., and IWATSURU, M., International Journal of Pharmaceutics, 1999, 193, 97–106.
  • Molecular nanocapsules based on amphiphilic hyperbranched polyglycerols. SUNDER, A., KRAMER, M., HANSELMANN, R., MULHAUPT, R., and FREY, H., Angewandte Chemk-International Edition, 1999, 38, 3552–3555.
  • Monogalactosyldiacylglycerol confers fusogenicity to liposomal delivery systems and facil-itates targeting to hepatocytes. WISEMAN, D. J., CORDEIRO, C., FINLAY, B. B., and WEBB, M. S., Journal of Liposome Research, 1999, 9, 461–475.
  • Nanoparticle engineering for gas sensor optimisation: improved sol-gel fabricated nanocrys-talline 5n02 thick film gas sensor for NO2 detection by calcination, catalytic metal introduction and grinding treatments. DIEGUEZ, A., 14 -OMAN° RODRIGUEZ, A., MORANTE, J. R., KAPPLER, J., BARSAN, N., and GOPEL, W., Sensors and Actuators B-Chemical, 1999, 60, 125–137.
  • Nanoparticles from the vapor phase: Synthesis and characterization of Si, Ge, Mo03, and W03 nanocrystals. Li, S. T., GERMANENKO, I. N., and EL SHALL, M. S., Journal of Cluster Science, 1999, 10, 533–547.
  • Nanosphere lithography: Effect of the external dielectric medium on the surface plasmon resonance spectrum of a periodic array of sliver nanoparticles. JENSEN, T. R., DUVAL, M. L., KELLY, K. L., LAZARIDES, A. A., SCHATZ, G. C., and VAN DUYNE, R. P., Journal of Physical Chemistry B, 1999, 103, 9846–9853.
  • New electroactive tetrathiafulvalene-derivatized gold nanoparticles and their remarkably stable n.anoparticle films on electrodes. NAKAI, H., YOSHIHARA, M., and FUJIHARA, H., Langmuir, 1999, 15, 8574–8576.
  • New transient absorption observed in the spectrum of colloidal 01Se nanoparticles pumped with high-power femtosecond pulses. BURDA, C., LINK, S., GREEN, T. C., and EL SAVED, M. A., Journal of Physical Chemistry B, 1999, 103, 10775–10780.
  • Nifedipine-loaded PLGA microspheres: in vitro/in vivo comparison of drug release and polymer degradation. SANSDRAP, P., FONTAINE, J., and MOES, A. J., STP Pharma Sciences, 1999, 9, 443–446.
  • Nitric oxide inhibition of chain peroxidation in liposomal membranes: Detection of a novel cholesterol derivative. Gil:torn, A. W., and KoRYTowsm, W., Free Radical Biology and Medicine, 1999, 27, 219.
  • Nonlinear optical properties of CuxS and CuInS2 nanoparticles in sol-gel glasses.
  • MALYAREVICH, A. M., YUMASHEV, K. V., POSNOV, N. N., MIKHAILOV, V. P., GURIN, V. S., PROKOPENKO, V. B., ALEXEENKO, A. A., and MELNICHENKO, I. M., Journal of Applied Physics, 2000, 87, 212–216.
  • Novel polymers in microparticulate diagnostic agents. TORCHILIN, V. P., Chemtech, 1999, 29, 27–34.
  • Novel synthesis of monodispersed Pd/Ni nanoparticles. TERANISHI, T., and MIYAKE, M., Chemistry of Materials, 1999, 11, 3414–3417.
  • Observation of size-dependent melting in lipid nanoparticles. UNRUH, rr -UNJES, H., WESTESEN, K., and KOCH, M. H. J., Journal of Physical Chemistry B, 1999, 103, 10373–10377.
  • Oil-in-water liposomal emulsions: Characterization and potential use in vaccine delivery. MUDERHWA, J. M., MATYAS, G. R., SPITLER, L. E., and ALVING, C. R., Journal of Pharmaceutical Sciences, 1999, 88, 1332–1339.
  • Optical trapping of nanoparticles and microparticles by a Gaussian standing wave. ZEMANEK, P., JoNAs, A., SRAMEK, L., and LISKA, M., Optics Letters, 1999, 24, 1448–1450.
  • Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. DRUMMOND, D. C., MEYER, 0., HONG, K. L., KIRPOTIN, D. B., and PAPAHADJOPOULOS, D., Pharmacological Reviews, 1999, 51, 691–743.
  • Optochemical sensing by immobilizing fluorophore-encapsulating liposomes in sol-gel thin films. NGUYEN, T., MCNAMARA, K. P., and ROSENZWEIG, Z., Analytica Chimica Acta, 1999, 400, 45–54.
  • Oral tolerance elicited in mice by beta-lactogjobulin entrapped in biodegradable micro-spheres. PECQUET, S., LEO, E., FRITSCHE, R., PFEIFER, A., COUVREUR, P., and FATTAL, E., Vaccine, 2000, 18, 1196–1202.
  • Pedestal antiresonant reflecting waveguides for robust coupling to microsphere resonators and for microphotonic circuits. LITTLE, B. E., LAINE, J. P., Lim, D. R., HAus, H. A., KIMERLING, L. C., and CHU, S. T., Optics Letters, 2000, 25, 73–75.
  • Pegylated liposomal doxorubicin (CAELYX(R)), administered intravenously at conventional dosages, penetrates into the brain. CZEJKA, M., BRAUNSDORFER, M., STRAUCH, S., and DITTRICH, C., Clinical Cancer Research, 1999, 5, 448.
  • Peroral immunization of microencapsulated human VP8*in combination with cholera toxin induces intestinal antibody responses. KANG, D. K., KIM, P. H., Ko, E. J., SEO, J. Y., SEONG, S. Y., KIM, Y. H., KWON, I. C., JEONG, S. Y., and YANG, J. M., Molecules and Cells, 1999, 9, 609–616.
  • Pharmacokinetics and organ distribution of cyclosporin A incorporated in liposomes and mixed micelles. LEE, M. K., CHOI, L., KIM, M. H., and KIM, C. K., International Journal of Pharmaceutics, 1999, 191, 87–93.
  • Pharrnacokinetics of liposomal aerosolized cyclosporine A for pulmonary immunosuppres-sion. LETSOU, G. V., SA, H. J., REARDON, M. J., ERGENOGLU, M., LI, Z., KLONARIS, C. N., BALDWIN, J. C., GILBERT, B. E., and WALDREP, J. C., Annals of Thoracic Surgery, 1999, 68, 2044–2048.
  • Pharmacokinetics of oligodeoxynucleotides encapsulated in liposomes: effect of lipid com-position and preparation method. ALINO, S. F., CRESPO, J., TARRASON, G., BLAYA, C., ADAN, J., ESCRIG, E., BENET, M., CRESPO, A., PERIS, J. E., and PRJLATS, J., Xenobiotica, 1999, 29, 1283–1291.
  • Pharmacokinetics of oral zidovudine entrapped in biodegradable nanospheres in rabbits.
  • CALLENDER, D. P., JAYAPRAKASH, N., BELL, A., PETRAITIS, V., PETRAITIENE, R., CANDELARIO, M., SCHAUFELE, R., DUNN, J. M., SRI, S., WALSH, T. J., and BALLS, F. M., Antimicrobial Agents and Chemotherapy, 1999, 43, 3046.
  • Pharmacokinetics of sterically stabilized hexadecylphosphocholine liposomes versus con-ventional liposomes and free hexadecylphosphocholine in tumor-free and human breast carcinoma bearing mice. ARNDT, D., ZEISIG, R., FICHTNER, I., TEPPKE, A. D., and FAHR, A., Breast Cancer Research and Treatment, 1999, 58, 71–80.
  • Pharmacokinetics, tissue distribution and photodynamic therapy efficacy of liposomal-delivered hypocrellin A, a potential photosensitizer for tumor therapy. WANG, Z. J., HE, Y. Y., HUANG, C. G., HUANG, J. S., HUANG, Y. C., AN, J. Y., Gu, Y., and JIANG, L. J., Photochemistry and Photobiology, 1999, 70, 773–780.
  • Pharmacological studies of cisplatin encapsulated in long-circulating liposomes in mouse tumor models. BANDAK, S., GOREN, D., HOROWITZ, A., TZEMACH, D., and GABIZON, A., Anti-Cancer Drugs, 1999, 10, 911–920.
  • Phase I study of Caelyx (doxorubicin HCL, pegylated liposomal) in recurrent head and neck cancer (HN). CAPONIGRO, F., AVALLONE, A., RIVELLINI, F., BUDILLON, A., DI GENNARO, E., TONNA, F., MOZZILLO, N., MARCOLIN, P., COMELLA, P., and COMELLA, G., Clinical Cancer Research, 1999, 5, 447.
  • Phase I study of liposomal daunorubicin (daunoxome) in relapsed and refractory acute myeloid leukemia. LERCHENMULLER, C., BUCHNER, T., and BERDEL, W. E., Blood, 1999, 94, 4247.
  • Phase I study of liposomal daunorubicin (Daunoxome) in the treatment of metastatic breast cancer. THOMAS, A., SHIELDS, F., WELLS JORDAN, P., LLOYD, D., HUBBARD, A., STEWARD, W. P., and O'BYRNE, K. J., European Journal of Cancer, 1999, 35, 1178.
  • Phase II study of liposomal vincristine (lipoV) in relapsed or refractory adult acute ly:mpho-blastic leukemia (ALL). THOMAS, n A -ARRIS, A., O'BRIEN, S., CORTES, J., GILES, F. J., FADERL, S., KEATING, M. J., BURGE, C., CABANILLAS, F., and KANTARJIAN, H., Blood, 1999, 94, 4269.
  • Phase III study of liposome-encapsulated doxorubicin (TLC D-99) and cyclophosphamide (CPA) vs. epirubicin (EPI) and CPA in first-line treatment of metastatic breast cancer NBC). CHAN, S., DAVIDSON, N., JUOZAITYTE, E., ERDKAMP, F., HOOFTMAN, L., and AzARNIA, N., European Journal of Cancer, 1999, 35, 1263.
  • Phase segregation in binary Si02/1102 and Si02/Fe203 nanoparticle aerosols formed in a premixed flame. EHRMAN, S. H., FRIEDLANDER, S. K., and ZACHARIAH, M. R., Journal of Materials Research, 1999, 14, 45514561.
  • Phosphorescent analysis of lipid peroxidation products in liposomes LA-Russian. MAZHUL, V. M., and SHCHERBIN, D. G., Biofizika, 1999, 44, 676–681.
  • Photosensitive liposomes as 'cages' for laser-triggered solute delivery: the effect of bilayer cholesterol on kinetics of solute release. BISBY, R. H., MEAD, C., and MORGAN, C. G., FEBS Letters, 1999, 463, 165–168.
  • Physicochemical characterization and antimicrobial activity of benzathine penicillin G liposomes. PONTES, A. C. D., CAETANO, M. N. P., and SANTOS MAGALHAES, N. S., STP Pharma Scienes, 1999, 9, 419–427.
  • Piroxicam encapsulated in liposomes: Characterization and in vivo evaluation of topical anti-inflammatory effect. CANTO, G. S., DALMORA, S. L., and OLIVEIRA, A. G., Drug Development and Industrial Pharmacy, 1999, 25, 1235–1239.
  • Poly(2-hydroxyalkyl methacrylates) as stabilizers for colloidal noble metal nanoparticles. MAYER, A. B. R., and MARK, J. E., Polymer, 2000, 41, 1627–1631.
  • Poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) (pluronic)/poly(epsilon-caprolactone) (PCL) amphiphilic block copolymeric nanospheres—I. Preparation and characterization. HA, J. C., KIM, S. Y., and LEE, Y. M., Journal of Controlled Release, 1999, 62, 381–392.
  • Polymeric nanocapsules as drug delivery systems—A review. LEGRAND, P., BARRATT, G., MOSQUEIRA, V., FESSI, H., and DEVISSAGUET, J. P., STP Pharma Sciences, 1999, 9, 411-418. Possible involvement of platelet microparticles in serum lipoprotein (LDL) fraction as a carrier of platelet-activating factor (PAF). IWAMOTO, S. .KEDA, M., and KAWASAKI, T., Blood, 1999, 94, 3461.
  • Pre-clinical studies of therapeutic angiogenesis using hepatocyte growth factor (HGF) in rat hindlinab ischemia model: comparison of angiogenic activity of rHGF, HGF plasmid alone and HGF gene transfer using viral-liposome method. TANIYAMA, Y., MORISHITA, R., AOKI, M., and OGIHARA, T., Circulation, 1999, 100, 1672.
  • Preparation and characterisation of solvent-stabilised nanoparticulate platinum and palla-dium and their catalytic behaviour towards the enantioselective hydrogenation of ethyl pyruvate. COLLIER, P. J., Icco, J. A., and WHYMAN, R., Journal of Molecular Catalysis A—Chemical, 1999, 146, 149–157.
  • Preparation and characterization of hollow microcapsules for use as ultrasound contrast agents. NARAYAN, P., and WHEATLEY, M. A., Polymer Engineering and Science, 1999, 39, 2242–2255.
  • Preparation and characterization of Ni nanoparticles in an MCM mesoporous material. JUNG, J. S., CHAE, W. S., MCINTYRE, R. A., SEIP, C. T., WILEY, J. B., and O'CONNOR, C. J., Materials Research Bulletin, 1999, 34, 1353–1360.
  • Preparation and characterization of ordered nanoparticle and polymer composite multi-layers on colloids. CARUSO, F., and MOHWALD, H., Langmuir, 1999, 15, 8276–8281.
  • Preparation and characterization of polylactide-poly(ethylene glycol)-polylactide triblock polymers and a preliminary in vivo examination of the blood circulation time for the nanoparticles made therefrom. SAKURAI, K., NAKADA, Y., NAKAMURA, T., TUDOMI, R., MATUMOTO, J., and TAKAHASHI, Y., Journal of Macromolecular Science—Pure and Applied Chemistry, 1999, 36, 1863–1877.
  • Preparation and characterization of surface-coated ZnS nanoparticles. CHEN, S. A., and Liu, W. M., Langmuir, 1999, 15, 8100–8104.
  • Preparation and studies of Ag-Ti02 hybrid nanoparticles of core-shell structure. Znou, Y WANG, C. Y Liu, H. J., ZHu, Y. R., and CHEN, Z. Y., Materials Science and Engineering B—Solid State Materials for Advanced Technology, 1999, 67, 95–98.
  • Preparation of poly(gamma-benzyl-L-glutamate) microspheres by the precipitation polymer-ization. KIM, K. S., KIM, T. K., and GRAHAM, N. B., Polymer Journal, 1999, 31, 809–812.
  • Preparation of polymer-coated functionalized silver nanoparticles. QUARONI, L., and CHUMANOV, G., Journal of the American Chemical Society, 1999, 121, 10642–10643.
  • Preparation of polyurea microcapsules with different composition ratios: structures and thermal properties. HONG, K., and PARK, S., Materials Science and Engineering A—Structural Materials Properties Microstructure and Processing, 1999, 272, 418–421.
  • Preparation of polyurethane microcapsules with different soft segments and their character-istics. HONG, K., and PARK, S., Reactive & Functional Polymers, 1999, 42, 193–200.
  • Preparation of semiconductor nanoparticle-polyurea composites using reverse micellar systems via an in situ diisocyanate polymerization. HIRAI, T., WATANABE, T., and KOMASAWA, I., Journal of Physical Chemistry B, 1999, 103, 10120–10126.
  • Preparation of Ulex europaeus lectin-gliadin nanoparticle conjugates and their interaction with gastrointestinal MUCUS. EZPELETA, I., ARANGOA, M. A., IRACHE, J. M., STAINMESSE, S., CHABENAT, C., POPINEAL, Y., and ORECCHIONI, A. M., International Journal of Pharmaceutics, 1999, 191, 25–32.
  • Preparation of ZnS nanoparticles by electrospray pyrolysis. LENGGORO, I. W., OKUYAMA, K., DE LA MORA, J. F., and TOHGE, N., Journal of Aerosd Science, 2000, 31, 121–136.
  • Preparation, characterization, and drug release behaviors of drug-loaded epsilon-caprolac-toneft.,-lactide copolymer nanoparticles. -E, H. Y -U, -V YANG, S. C., JIANG, X. Q., and YANG, C. Z., Journal of Applied Polymer Science, 2000, 75, 874–882.
  • Primidone-loaded poly-epsilon-caprolactone nanocapsules: incorporation efficiency and in vitro release profiles. FERRANTI, V., MARCHAIS, H., CHABENAT, C., ORECCHIONI, A. M., and LAFONT, 0., International Journal of Pharmaceutics, 1999, 193, 107–111.
  • Production of hollow microspheres from nanostructured composite particles. CARUSO, F., CARUSO, R. A., and MOHWALD, H., Chemistry of Materials, 1999, 11, 3309–3314.
  • Prolongation of brachial plexus block withl3upivacaine-loaded microspheres. ESTEBE, J. P., LE CORRE, P., Du PLESSIS, L., LE VERGE, R., and ECOEY, C., Anesthesiology, 1999, 91, A923.
  • Prolonged circulation time of doxorubicin-loaded liposomes coated with a modified poly-vinyl alcohol after intravenous injection in rats. TAKEUCHI, H., KOJIMA, H., TOYODA, T., YAMAMOTO, H., HINO, T., and KAWASHIMA, Y., European Journal of Pharmaceutics and Biopharmaceutics, 1999, 48, 123–129.
  • Prophylaxis of regional node metastases with liposomes. POPOVA, N. A., NIKOLIN, V. P., and Ku 'DIN, V. I., Bulletin of Experimental Biology and Medicine, 1999, 127, 408–409.
  • Protection of microvascular reflow by endothelin antagonist treatment: Evaluation with fluorescent microspheres and myocardial contrast echocardiography. GALIUTO, L., DI MARIA, A. N., DEL BALZO, U., MAY NEWMAN, K., FLAIM, S. F., KIRCHENGAST, M., and ILICETO, S., Circulation, 1999, 100, 1058.
  • Protective effect caused by the exopolymer excreted by Pseudoalteromonas antarctica NF3 on liposomes against Triton X-100. DE LA MAZA, A., LOPEZ, 0., COCERA, M., CODERCH, L., PARRA, J. L., and GUINEA, J., Colloid and Polymer Science, 1999, 277, 1200–1204.
  • Pulsed sonoelectrochemical synthesis of cadmium selenide nanoparticles. MASTAI, Y., POLSKY, R., KOLTYPIN, Y., GEDANKEN, A., and HODES, G., Journal of the American Chemical Society, 1999, 121, 10047–10052.
  • Pyrene micropartitioning and solubilization by sodium dodecyl sulfate complexes with poly(ethylene glycol). KIM, J. H., DomAcn, M. M., and TumoN, R. D., Journal of Physical Chemistry B, 1999, 103, 10582–10590.
  • Radionuclide sensors based on chemically selective scintillating microspheres: Renewable column sensor for analysis of Tc-99 in vvater. EGOROV, 0. B., FISKUM, S. K., O'HARA, M. J., and GRATE, J. W., Analytical Chemistry, 1999, 71, 5420–5429.
  • Rapid remission induction with CLAD (Cyclophosphamide Liposomal Doxorubicin, Dexamethasone) in patients with advanced multiple myeloma. SZELENYI, H., KEILHOLZ, U., MENSSEN, H. D., SCHMITTEL, A., SIEHL, J., and THIEL, E., Blood, 1999, 94, 4633.
  • Reactivity of singlet oxygen with tryptophan residues and with melittin in liposome systems. VILENSKY, A., and FEITELSON, J., Photochemistry and Photobiology, 1999, 70, 841–846.
  • Real-time measurements of DNA hybridization on microparticles with fluorescence reson-ance energy transfer. HENRY, M. R., STEVENS, P. W., SUN, J., and KELSO, D. M., Analytical Biochemistry, 1999, 276, 204–214.
  • Recombinant human bone morphogenetic protein-2 binding and incorporation in PLGA microsphere delivery systems. SCHRIER, J. A., and DE LucA, P. P., Pharmaceutical Development and Technology, 1999, 4, 611–621.
  • Relative roles of metal ions and singlet oxygen in UVA-induced liposomal lipid peroxidati on. SHIH, M. K., and Hu, M. L., Journal of Inorganic Biochemistry, 1999, 77, 225–230.
  • Reperfusion pattern of the immature femoral head after critical ischemia—A microsphere study in pigs. DRESCHER, W., SCHNEIDER, T., BECKER, C., HOBOLTH, L., RUTHER, W., BUNGER, C., and HANSEN, E. S., Acta Orthopaedka Scandinavka, 1999, 70, 439–445.
  • Resolving liposomal inhibition of quantitative LAL methods. PiLuso, L. G., and MARTINEZ, M. Y., PDA Journal of Pharmaceutical Science and Technology, 1999, 53, 260–263.
  • Resonant and off-resonant light-driven plasmons in metal nanoparticles studied by femto-second-resolution third-harmonic generation. LAMPRECHT, B., KRENN, J. 14-EITNER, A., and AUSSENEGG, F. R., Physical Review Letters, 1999, 83, 4421–4424.
  • Response surface methodology as a predictive tool for determining the effects of preparation conditions on the physicochemical properties of poly(isobutylcyanoacrylate) nanopar-tides. MCCARRON, P. A., WOOLFSON, A. D., and KEATING, S. M., International Journal of Pharmaceutics, 1999, 193, 37–47.
  • Reversion of multi drug resistance by co-encapsulation of doxorubicin and cyclosporin A in polyalkylcyanoacrylate nanoparticles. SomA, C. E., n -UBERNET, C., BENTOLILA, D., BENITA, S., and COUVREUR, P., Biomaterials, 2000, 21, 1–7.
  • Role of drug release and liposome-mediated drug delivery in governing the therapeutic activity of liposomal mitoxantrone used to treat human A431 and IS180 solid tumors. Lim, H. J., MASIN, D., MCINTOSH, N. L., MADDEN, T. D., and BALLY, M. B., Journal of Pharmacology and Experimental Therapeutics, 2000, 292, 337–345.
  • Safely and phannacokinetics of a new liposomal liver-specific contrast agent for Cr—Results of clinical testing in nonpatient volunteers. SPINAZZI, A., CERIATI, S., PIANEZZOLA, P., LORUSSO, V., LUZZANI, F., FOUILLET, X., ALVIN°, S., and RUMMENY, E. J., Investigative Radiology, 2000, 35, 1–7.
  • Safety and toxicokinetics of intravenous liposomal amphotericin B (ArnBisome(R)) in beagle dogs. BEKERSKY, I., BOSWELL, G. W., HILES, R., FIELDING, R. M., BUELL, D., and WALsn, T. J., Pharmaceutical Research, 1999, 16, 1694–1701.
  • Shaping nanoparticles and their optical spectra with photons. WENZEL, T., BOSBACH, J., GOLDMANN, A., STIETz, F., and TRAGER, F., Applied Physics B—Lasers and Optics, 1999, 69, 513–517.
  • Significant increase in antitumor potency of doxorubicin HC1 by its encapsulation in pegylated liposomes. COLBERN, G. T., HILLER, A. J., MUSTERER, R. S., PEGG, E., HENDERSON, I. C., and WORKING, P. K., Journal of Liposome Research, 1999, 9, 523–538.
  • Significant reduction in aggregation of G-CSF/dexamethasone mobilized granulocytes by liposomal amphotericin compared to amphotericin B: Implications for concurrent administration. HENDERSON, T. R., and CAIRO, AI. S., Blood, 1999, 94, 3331.
  • Silver-based crystalline nanoparticles, microbially fabricated. KLAUS, T., JOERGER, R., OLSSON, E., and GRANQVIST, C. G., Proceedings of the National Academy of Sciences (USA), 1999, 96, 13611–13614.
  • Simultaneous measurement of cardiac output and its distribution with microspheres in the rat. MCDEVITT, D. G., Cardiovascular Research, 2000, 45, 11–12.
  • Simultaneous measurement of cardiac output and its distribution with microspheres in the rat. MCDEVITT, D. G., and NIES, A. S., Cardiovascular Research, 2000, 45, 9–10.
  • Size dependence of the energy relaxation in silver nanoparticles embedded in dielectric matrices. HALTE, V., BIGOT, J. Y., PALPANT, B., BROYER, M., PREVEL, B., and PEREZ, A., Applied Physics Letters, 1999, 75, 3799–3801.
  • Stabilization of pH-induced degradation of porcine insulin in biodegradable polyester microspheres. SHAD, P. G., and BAILEY, L. C., Pharmaceutical Development and Technology, 1999, 4, 633–642.
  • Stable expression of green fluorescent protein after liposomal transfection of K562 cells without selective growth conditions. GUBIN, A. N., KODURU, S., NJOROGE, J. M., BHATNAGAR, R., and MILLER, J. L., Biotechniques, 1999, 27, 1162–1169.
  • Stimuli-response of microsphere having poly(N-isopropylacrylamide) shell. MATSUOKA, H., FUJIMOTO, K., and KAWAGUCHI, H., Polymer Journal, 1999, 31, 1139–1144.
  • Study of the effect of formamide and N,N-dimethylformamide on the synthesis of CdS nanoparticles in a Si02 matrix by sol-gel method. GUAITA, F. J., CORDONCILLO, E., BELTRAN, H., ESCRIBANO, P., and CALBET, J. M. G., Solid State Sciences, 1999, 1, 351–364.
  • Study of the growth of ZnS nanoparticles in water/AOT/n-heptane microemulsions by UV-absorption spectroscopy. CALANDRA, P., GOREDI, M., and LIVERI, V. T., Colloids and Surfaces A—Physicochemical and Engineering Aspects, 1999, 160, 9–13.
  • Study on the anticarcinogenic effect and acute toxicity of liver-targeting mitoxantrone-nanoparticles. ZHANG, Z. R., HE, Q., LIAO, G. T., and BAI, S. H., World Journal of Gastroenterology, 1999, 5, 511–514.
  • Study on the structure and tribological properties of surface-modified Cu nanoparticles. ZHOU, J. F., YANG, J. J., ZHANG, Z. J., LIU, W. M., and XUE, Q. J., Materials Research Bulletin, 1999, 34, 1361–1367.
  • Successful unrelated BMT for AML in second complete remission with pulmonary asper-gillosis by use of liposomal amphotericin (Ambisome(R)). SWEETMAN, R. W., and ROSENTHAL, J., Blood, 1999, 94, 4893.
  • Surface adhesion properties of platelet derived microparticles. YEO, E. L., and MISCEVIC, N. M., Blood, 1999, 94, 3459.
  • Surface and internal spin canting in gamma-Fe203 nanoparticles. MORALES, M. P., VEINTEMILLAS VERDAGUER, S., MONTERO, M. I., SERNA, C. J., Rob, A., CASAS, L., MARTINEZ, B., and SANDIUMENGE, F., Chemistry of Materials, 1999, 11, 3058–3064.
  • Surface interactions in emulsions and liposome solutions. BLOMBERG, E., CLAESSON, P. M., and WARNHEIM, T., Colloids and Surfaces A—Physicochemical and Engineering Aspects, 1999, 159, 149-15 7.
  • Surface modification of CdS nanoparticles with MoS42-: A case study of nanoparticle-modifier electronic interaction. DIAZ, D., ROBLES, J., NI, T., CASTILLO BLUM, S. E., NAGESHA, D., ALVAREZ FREGOSO, 0. J., and Kurov, N. A., Journal of Physical Chemistry B, 1999, 103, 9859–9866.
  • Sustained release of 17 beta-estradiol from poly(lactide-co-glycolide) microspheres in vitro and in vivo. MOGI, T., OHTAKE, N., YOSHIDA, M., CHIMURA, R., KAMAGA, Y., ANDO, S., TSUKAMOTO, T., NAKAJIMA, T., UENODAN, H., OTSUKA, M., MATSUDA, Y., OHSHIMA, H., and MAKINO, K., Colloids and Surfaces B—Biointerfaces, 2000, 17, 153–165.
  • Synthesis and characterization of nanoscopic entities based on poly(caprolactone)-grafted cadmium sulfide nanoparticles. CARROT, G., SCHOLZ, S. M., PLUMMER, C. J. G., HILBORN, J. G., and HEDRICK, J. L., Chemistry of Materials, 1999, 11, 3571–3577.
  • Synthesis and characterization of poly(N-isopropylacrylamide)-coated polystyrene micro-spheres with silver nanoparticles on their surfaces. CHEN, C. W., SERIZAWA, T., and AKASHI, M., Langmuir, 1999, 15, 7998–8006.
  • Synthesis and properties of selective metal-complexing nanoparticles. AMIGONI GERBIER, S., and LARPENT, C., Macromolecules, 1999, 32, 9071–9073.
  • Synthesis and ultrafast study of cysteine- and glutathione-capped Ag25 semiconductor colloidal nanoparticles. BRELLE, M. C., ZHANG, J. Z., NGUYEN, L., and MEHRA, R. K., Journal of Physical Chemistry A, 1999, 103, 10194–10201.
  • Synthesis of aqueous magnetic liquids by surface complexation of maghemite nanoparticles. FAUCONNIER, N., BEE, A., ROGER, J., and PONS, J. N., Journal of Molecular Liquids, 1999,83, 233–242.
  • Synthesis of nanoparticles in Langmuir monolayer. KHOMUTOV, G. B., OBYDENOV, A. Y., YAKOVENKO, S. A., SOLDATOV, E. S., TRIFONOV, A. S., KHANIN, V. V., and GUBIN, S. P., Materials Science & Engineering C—Biomimetic and Supramolecular Systems, 1999, 309–318.
  • Synthesis of polymer microspheres with mercapto groups by polycondensation of alpha, omega-alkanedithiol and alpha,omega-dibromoalkane in the presence of a polystyrene latex. WATANABE, S., SHISHIDO, 0., TAKANO, S., MURATA, M., and MASUDA, Y., Macromolectdar Chemistry and Physics, 1999, 200, 2577–2580.
  • Synthesis of spherical nanoparticles of Cu2L205 (L = Ho, Er) from W/O microemulsions. PORTA, F., BIFULCO, C., FERMO, P., BIANCHI, C. L., FADONI, M., and PRATI, L., Colloids and Surfaces A—Physicochemkal and Engineering Aspects, 1999, 160, 281–290.
  • Tailoring of the external and internal morphology of poly-3-hydroxy butyrate microparticles. MARTIN, M. A., MIGUENS, F. C., RIEUMONT, J., and SANCHEZ, R., Colloids and Surfaces B—Biointerfaces, 2000, 17, 111–116.
  • Targeted delivery of antibiotics using liposomes and nanoparticles: research and applica-tions. PINTO ALPHANDARY, H., ANDREMONT, A., and COUVREUR, P., International Journal of Antimicrobial Agents, 2000, 13, 155–168.
  • Template-assisted growth of hexagonal poly- or single-crystalline quasi-2D palladium nano-particles. WALTER, J., Advanced Materials, 2000, 12, 31–34.
  • The adsorption of linear poly(N-isopropylacrylamide) chains on surfactant-free polystyrene nanoparticles. GAO, J., Hu, T. J., ZHANG, Y. B., LI, P., and Wu, C., Chinese Journal of Polymer Science, 1999, 17, 595–601.
  • The antifibrogenic effects of liposome-encapsulated IFN-alpha 2b cream on skin wounds. TAKEUCHI, M., TREDGET, E. E., SCOTT, P. G., KILANI, R. T., and GHAHARY, A., Journal of Interferen and Cytokine Research, 1999, 19, 1413–1419.
  • The effect of isoprene on the properties of spinach thylakoids and phosphatidylcholine liposomes. LOGAN, B. A., ANCHORDOQUY, T. J., MONSON, R. K., and PAN, R. S., Plant Biology, 1999, 1, 602–606.
  • The potential of liposomes as a nutrient supplement in first-feeding marine fish larvae. KOVEN, W., BARR, Y., HADAS, E., BEN ATIA, I., CHEN, Y., WEISS, R., and TANDLER, A., Aquaculture Nutrition, 1999, 5, 251–256.
  • The preparation and some properties of a liposome formulation of 2,4-di(1-methy1-3-hydro-xybutylldeuteroporphyrin IXLA-Russian. RESHETNICKOV, A. V., ZHIGALTSEV, I. V., KOLOMEICHUK, S. N., KAPLUN, A. P., SHVETS, V. I., ZHUKOVA, 0. S., KARMENYAN, A. V., IvANov, A. V., and PONOMAREV, G. V., Bioorgankheskaya Khimiya, 1999, 25, 782–790.
  • The study of the process of fluid-phase endocytosis in cervical squamous cells using fluorescent microspheres. HEW, W. S. R., ROBERTSON, A. J., Ross, P., and HOPWOOD, D., Cytopathology, 1999, 10, 375–382.
  • The use of liposome encapsulated MUC-1 for ex vivo pulsing of dendritic cells for immu-notherapy of metastatic breast cancer. DOWNING, I., CAMPBELL, J., FRASER, R., KRANZ, M., TURNER, M., and FRANKLIN, I., Transfusion, 1999, 39, S37.
  • Tissue-targeted acoustic cationic liposomes: Potential for directed gene delivery. TIUKINHOY, S. D., NAGARAJ, A., KLEGERMAN, M. E., KANE, B. J., MACDONALD, R. C., MATSUMURA, J. S., and MCPHERSON, D. D., Circulation, 1999, 100, 2338.
  • Transferrin-liposome-mediated systemic p53 gene therapy in combination with radiation results in regression of human head and neck cancer xenografts. XU, L. A PIROLLO, K. F., TANG, W. H., RAIT, A., and CHANG, E. H., Human Gene Therapy, 1999, 10, 2941–2952.
  • Translucent acrylic nanocomposites containing =isotropic laminated nanoparticles derived from intercalated layered silicates. DIETSCHE, F., THOMANN, Y., THOMANN, R., and Muuukuvr, R., Journal of Applied Polymer Science, 2000, 75, 396–405.
  • Treatment of documented deep fungal infections in patients with sibling or unrelated stem cell transplantation: A study comparing safety and efficacy of conventional amphoter-icin B to liposomal amphotericin B (ambisorne(R)). FAUSER, A. A., BLAU, I. W., BASARA, N., RUDOLPHI, M., ROEMER, E., BISCHO, M., GUNZELMANN, S., KIRSTEN, D., and KIEHL, M. G., European Journal of Cancer, 1999, 35, 1191.
  • Tumor growth suppression by boron neutron capture therapy with 10B entrapperd PEG-liposome in pancreatic cancer model in vivo. YANAGIE, H., MARUYAMA, K., TAKIZAWA, T., OGURA, K., SAKURAI, Y., KOBAYASHI, T., ONO, K., ERIGUCHI, M., and KOBAYASHI, H., European Journal of Cancer, 1999, 35, 717.
  • Tumor-targeted gene delivery by ligand-PEG 'post-coated' cationic liposomes. Xu, L., and CHANG, E. H., Clinical Cancer Research, 1999, 5, 502.
  • Utility of liposomes coated with polysaccharide bearing 1-a:minolactose as targeting chemo-therapy for AH66 hepatoma cells. YAMAMOTO, M., ICHINOSE, K., I,,H11, N., KHOJI, T., AKIYOSHI, K., MORIGUCHI, N., SUNAMOTO, J., and KANEMATSU, T., Oncology Reports, 2000, 7, 107–111.
  • Validation of fluorescent-labeled microspheres for measurement of relative blood flow in severely injured lungs. HUBLER, M., SOUDERS, J. E., SHADE, E. D., HLASTALA, M. P., POLISSAR, N. L., and GLENNY, R. W., Journal of Applied Physiology, 1999, 87, 2381–2385.
  • Viral microencapsulation delays protection after intramuscular inoculation of mice with rotavirus. COIN, S. E., MOSER, C. A., COHEN, S., SPEAKER, T. J., and OIT, P. A., Drug Delivery, 1999, 6, 253–257.
  • Voltammetry of organic microparticles. KOMORSKY LOVRIC, S., MIRCESKI, V., and SCHOLZ, F., Mikrochimica Acta, 1999, 132, 67–77.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.